Arab Pharmaceutical Manufacturing

Arab Pharmaceutical Manufacturing Company (APM) was a Jordanian pharmaceutical and healthcare manufacturer headquartered in Amman. Founded in 1962, it became one of the country's established medicine producers, manufacturing dozens of pharmaceutical products for the domestic Jordanian market and for export. Its production operations were centered on two facilities located at Al Salalem and Al-Buhayra. APM's business combined local pharmaceutical manufacturing with international distribution. In addition to supplying Jordan, the company exported medicines to Saudi Arabia, European markets, and the United States. Its international activities also included cooperation with overseas pharmaceutical organizations, including Japan's Takeda Pharmaceutical Company. These relationships placed APM within the broader network of Middle Eastern pharmaceutical manufacturers seeking to develop export capabilities and international partnerships. The company was also part of Jordan's public capital market. While it was operating independently, APM was included in the Amman Stock Exchange's ASE Weighted Index. This reflected its status as a publicly traded Jordanian pharmaceutical company rather than only a private manufacturing operation. Hikma Pharmaceuticals acquired APM in 2007. Following the acquisition, the business continued to operate under the APM brand for several years. The brand remained in use until 2017, after which APM no longer operated as an independent active brand according to the available reference material. The acquisition linked APM's manufacturing assets and product portfolio to Hikma's wider pharmaceutical group. APM's historical significance rests primarily on its role in Jordan's pharmaceutical manufacturing sector: it operated domestic production facilities, developed a broad product range, served both local and export markets, and maintained international industry relationships. Publicly available information does not identify a complete product catalogue, detailed financial history, executive roster, or the precise corporate disposition of each product line after the Hikma acquisition.

Arab Pharmaceutical Manufacturing Company was established in Jordan in 1962 and developed as a domestic pharmaceutical producer headquartered in Amman. Its operations included two principal manufacturing facilities, at Al Salalem and Al-Buhayra. The company produced dozens of pharmaceutical products, although the available reference does not provide a detailed list of product names, therapeutic categories, or individual launch dates. APM served Jordan's local medicine market while also developing an export business. Its products were exported to Saudi Arabia, Europe, and the United States. The company also worked with international pharmaceutical partners, including Takeda Pharmaceutical Company of Japan. These activities indicate that APM was not limited to supplying Jordanian customers; it also participated in cross-border pharmaceutical commerce and industrial cooperation. During its independent operating period, APM was listed on the Amman Stock Exchange and was included in the exchange's ASE Weighted Index. The available source does not provide its ticker, market capitalization, revenue, profitability, or other financial figures, so those details cannot be stated reliably here. A major turning point came in 2007, when Hikma Pharmaceuticals acquired APM. After the transaction, APM continued to operate under its established name rather than disappearing immediately as a commercial identity. The brand remained in use until 2017. Available material does not specify whether all facilities, products, registrations, or employees were transferred directly into Hikma operations, nor does it describe the precise legal steps by which the APM brand was retired. APM's historical role was therefore that of a Jordanian pharmaceutical manufacturer with local production capacity, export reach, public-market participation, and international partnerships. Its later history was shaped by its integration into Hikma Pharmaceuticals. Because the surviving public information is concise, a complete account of its management, product portfolio, financial performance, regulatory record, and post-acquisition asset structure would require additional primary or archival sources.

1. 2017APM brand discontinued

   The APM brand ceased operating after continuing under Hikma ownership for approximately a decade.

   Source
2. 2007Acquired by Hikma Pharmaceuticals

   Hikma Pharmaceuticals acquired APM. The acquired business continued using the APM brand after the transaction.

   Source
3. 1962Company founded

   Arab Pharmaceutical Manufacturing was founded in Jordan and began developing its pharmaceutical manufacturing operations.

   Source
4. Expansion into export markets

   During its operating history, APM supplied Jordan and exported medicines to Saudi Arabia, Europe, and the United States. The company also worked with international partners including Takeda Pharmaceutical Company.

   Source

A Jordanian pharmaceutical manufacturer focused on producing medicines for the domestic market and export markets.

• Pharmaceutical medicinesPharmaceutical products

  APM produced dozens of pharmaceutical products for use in Jordan and for export. The available reference does not identify the medicines by brand name, active ingredient, dosage form, or therapeutic area, so the portfolio is best described at the company level rather than through unsupported product claims.

• 2007Acquisition by Hikma PharmaceuticalsM&A

  APM was an established Jordanian pharmaceutical manufacturer with domestic production facilities, export activity, and public-market participation.

  What changed. Hikma Pharmaceuticals acquired Arab Pharmaceutical Manufacturing. APM continued operating under its own brand after the acquisition.

  Aftermath. The APM brand remained in use until 2017. The available material does not specify the detailed integration of facilities, products, or personnel into Hikma.

  Source

• 2017Arab Pharmaceutical Manufacturing brand ceased operating

  The APM brand, which had continued after Hikma's acquisition, was no longer operating as an independent brand by 2017.

  Other
  Source
• 2007Hikma Pharmaceuticals acquired Arab Pharmaceutical Manufacturing

  Hikma Pharmaceuticals acquired APM. The company subsequently continued operating under the APM brand for a period before the brand ceased operating in 2017.

  M&A
  Source

1. Arab Pharmaceutical Manufacturing